Mitochondrial Sirtuin 3 and Renal Diseases

Nephron

Volumn 134, Issue 1, 2016, Pages 14-19

  Perico, Luca ^a   Morigi, Marina ^a   Benigni, Ariela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Mitochondria; Renal diseases; Sirtuin 3

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HONOKIOL; LEVACECARNINE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PEROXIREDOXIN 3; PEROXIREDOXIN 5; REACTIVE OXYGEN METABOLITE; SIRTUIN 3;

ACUTE KIDNEY FAILURE; AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELLULAR PARAMETERS; DRUG MECHANISM; DRUG TARGETING; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HEART VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; KIDNEY DISEASE; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL STRUCTURE; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM;

AGING; ANIMALS; HUMANS; KIDNEY DISEASES; MITOCHONDRIA; SIRTUIN 3;

EID: 84978044209     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000444370     Document Type: Review

References (32)

1. Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z: Regulated cell death in AKI. J Am Soc Nephrol 2014;25:2689-2701.
2. Ernster L, Schatz G: Mitochondria: a historical review. J Cell Biol 1981;91:227S-255S.
3. Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J: Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med 2007;39:335-345.
4. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T: A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A 2008;105:14447-14452.
5. Finley LW, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, Gygi SP, Haigis MC: Succinate dehydrogenase is a direct target of Sirtuin 3 deacetylase activity. PLoS One 2011;6:e23295.
6. Rahman M, Nirala NK, Singh A, Zhu LJ, Taguchi K, Bamba T, Fukusaki E, Shaw LM, Lambright DG, Acharya JK, Acharya UR: Drosophila Sirt2/mammalian SIRT3 deacetylates ATP synthase beta and regulates complex V activity. J Cell Biol 2014;206:289-305.
7. Koehler CM: Protein translocation pathways of the mitochondrion. FEBS Lett 2000;476:27-31.
8. Guarente L: The many faces of sirtuins: sirtuins and the Warburg effect. Nat Med 2014;20:24-25.
9. Pham-Huy LA, He H, Pham-Huy C: Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89-96.
10. Bell EL, Guarente L: The SirT3 divining rod points to oxidative stress. Mol Cell 2011;42:561-568.
11. Galluzzi L, Kepp O, Kroemer G: Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 2012;13:780-788.
12. Kinnally KW, Peixoto PM, Ryu SY, Dejean LM: Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim Biophys Acta 2011;1813:616-622.
13. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, Sinclair DA: Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010;2:914-923.
14. Hoppins S, Lackner L, Nunnari J: The machines that divide and fuse mitochondria. Annu Rev Biochem 2007;76:751-780.
15. Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, Mihara K: Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol 2010;191:1141-1158.
16. Youle RJ, Narendra DP: Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011;12:9-14.
17. Samant SA, Zhang HJ, Hong Z, Pillai VB, Sundaresan NR, Wolfgeher D, Archer SL, Chan DC, Gupta MP: SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol 2014;34:807-819.
18. Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, Boersma MD, Carson JJ, Tonelli M, Balloon AJ, Higbee AJ, Westphall MS, Pagliarini DJ, Prolla TA, Assadi-Porter F, Roy S, Denu JM, Coon JJ: Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 2013;49:186-199.
19. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G: A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005;85:258-263.
20. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G: Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 2009;119:524-530.
21. Macconi D, Perico L, Longaretti L, Morigi M, Cassis P, Buelli S, Perico N, Remuzzi G, Benigni A: Sirtuin3 dysfunction is the key determinant of skeletal muscle insulin resistance by angiotensin II. PLoS One 2015;10:e0127172.
22. Sundaresan NR, Bindu S, Pillai VB, Samant S, Pan Y, Huang JY, Gupta M, Nagalingam RS, Wolfgeher D, Verdin E, Gupta MP: SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating GSK3beta. Mol Cell Biol 2015;pii:MCB.00586-15.
23. Morigi M, Perico L, Rota C, Longaretti L, Conti S, Rottoli D, Novelli R, Remuzzi G, Benigni A: Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest 2015;125:715-726.
24. Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G: International society of nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 2015;385:2616-2643.
25. Koyama T, Kume S, Koya D, Araki S, Isshiki K, Chin-Kanasaki M, Sugimoto T, Haneda M, Sugaya T, Kashiwagi A, Maegawa H, Uzu T: SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med 2011;51:1258-1267.
26. Zhuo L, Fu B, Bai X, Zhang B, Wu L, Cui J, Cui S, Wei R, Chen X, Cai G: NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell Physiol Biochem 2011;27:681-690.
27. Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP: Mitochondrial SIRT3 and heart disease. Cardiovasc Res 2010;88:250-256.
28. Duan W: Sirtuins: from metabolic regulation to brain aging. Front Aging Neurosci 2013;5:36.
29. Weir HJ, Lane JD, Balthasar N: SIRT3: a central regulator of mitochondrial adaptation in health and disease. Genes Cancer 2013;4:118-124.
30. Chen Y, Fu LL, Wen X, Wang XY, Liu J, Cheng Y, Huang J: Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis 2014;5:e1047.
31. Jasper H: Sirtuins: longevity focuses on NAD+. Nat Chem Biol 2013;9:666-667.
32. Pillai VB, Samant S, Sundaresan NR, Raghuraman H, Kim G, Bonner MY, Arbiser JL, Walker DI, Jones DP, Gius D, Gupta MP: Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nat Commun 2015;6:6656.